Skip to main content
Log in

Blockade of the Fas/Fas ligand interaction suppresses hepatocyte apoptosis in ischemia-reperfusion rat liver

  • Original Paper
  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

Hepatic ischemia-reperfusion injury remains a significant problem for liver surgery, including transplantation, and apoptosis has been implicated in this type of hepatic injury. Here we found that through the Fas/Fas ligand interaction apoptosis is involved in the late phase of hepatic ischemia-reperfusion injury. The appearance of apoptotic hepatocytes increases significantly after reperfusion, reaching a maximum 12 h after reperfusion. The transcription levels of Fas and Fas ligand are increased after reperfusion. Fas is expressed on hepatocytes, while Fas ligand is expressed on infiltrating immune cells. A close spatial and temporal association of Fas expression and apoptotic cells is demonstrated in the histological observation. These results suggest that infiltrating cells induce apoptosis of hepatocytes through the Fas/Fas ligand interaction, leading to hepatocyte injury. Furthermore, an injection of anti-Fas antibody or neutralizing anti-Fas ligand antibody results in a dramatic decrease in the occurrence of hepatocyte apoptosis and hepatic infiltration of macrophages and natural killer cells as well as liver injury. Our results suggest that blockage of the Fas/Fas ligand interaction is a promising strategy for suppression of hepatic ischemia-reperfusion injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Bismuth H, Castaing D, Garden OJ (1989) Major hepatic resection under total vascular exclusion. Ann Surg 210:13–19. doi:10.1097/00000658-198907000-00002

    Article  PubMed  CAS  Google Scholar 

  2. Starzl T, Bell R, Beart R, Putnam R (1975) Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet 141:429–437

    PubMed  CAS  Google Scholar 

  3. Clavien PA, Harvey PRC, Strasberg SM (1992) Preservation and reperfusion injury allografts: overview and synthesis of current studies. Transplantation 53:957–978. doi:10.1097/00007890-199205000-00001

    Article  PubMed  CAS  Google Scholar 

  4. Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ (2000) Inflammatory mechanisms and therapeutic strategies for worm hepatic ischemia/reperfusion injury. Hepatology 32:169–173. doi:10.1053/jhep.2000.9323

    Article  PubMed  CAS  Google Scholar 

  5. Schwabe RF, Brenner DA (2006) Mechanisms of liver injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 290:G583–G589. doi:10.1152/ajpgi.00422.2005

    Article  PubMed  CAS  Google Scholar 

  6. Jaeschke H, Smith CW (1997) Mechanisms of neutrophil induced parenchymal cell injury. J Leukoc Biol 61:647–653

    PubMed  CAS  Google Scholar 

  7. Schlayer HJ, Laaff H, Peters T et al (1988) Involvement of tumor necrosis factor in endotoxin-triggered neutrophils adherence to sinusoidal endothelial cells of mouse liver and its modulation in acute phase. J Hepatol 7:239–249. doi:10.1016/S0168-8278(88)80488-4

    Article  PubMed  CAS  Google Scholar 

  8. Edelstein CL, Wieder ED, Yaqoob MM et al (1995) The role of cysteine proteases in hypoxia-induced rat renal proximal tubular injury. Proc Natl Acad Sci USA 92:7662–7666. doi:10.1073/pnas.92.17.7662

    Article  PubMed  CAS  Google Scholar 

  9. Nichols JC, Bronk SF, Gores GJ (1994) Inhibition of nonlysosomal calcium-dependent proteolysis by glycine during anoxic injury of rat hepatocytes. Gastroenterology 106:168–176

    PubMed  CAS  Google Scholar 

  10. Kohli V, Gao W, Camargo CA, Clavien PA (1997) Calpain is a mediator of preservation: reperfusion injury in rat liver transplantation. Proc Natl Acad Sci USA 94:9354–9359. doi:10.1073/pnas.94.17.9354

    Article  PubMed  CAS  Google Scholar 

  11. Aguilar HI, Steers JL, Weisner RH, Krom RAF, Gores GJ (1997) Enhanced liver calpain protease activity is a risk factor for dysfunction of human liver allograft. Transplantation 63:612–614. doi:10.1097/00007890-199702270-00023

    Article  PubMed  CAS  Google Scholar 

  12. Vivek K, Markus S, John FM, Rex CB, Pierre AC (1999) Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 67:1099–1105. doi:10.1097/00007890-199904270-00003

    Article  Google Scholar 

  13. Li SQ, Liang LJ, Huang JH, Li Z (2003) Hepatocyte apoptosis induced by hepatic ischemia-reperfusion injury in cirrhotic rats. Hepatobiliary Pancreat Dis Int 2:102–105

    PubMed  CAS  Google Scholar 

  14. Rudiger HA, Clavien PA (2002) Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology 122:202–210. doi:10.1053/gast.2002.30304

    Article  PubMed  CAS  Google Scholar 

  15. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL (1994) Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94:1621–1628. doi:10.1172/JCI117504

    Article  PubMed  CAS  Google Scholar 

  16. Itoh N, Yonehara S, Ishii A et al (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233–243. doi:10.1016/0092-8674(91)90614-5

    Article  PubMed  CAS  Google Scholar 

  17. Suda T, Takahashi T, Golstein P, Nagata S (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169–1178. doi:10.1016/0092-8674(93)90326-L

    Article  PubMed  CAS  Google Scholar 

  18. Kayagaki N, Kawasaki A, Ebata T et al (1995) Metalloproteinase-mediated release of human Fas ligand. J Exp Med 182:1777–1783. doi:10.1084/jem.182.6.1777

    Article  PubMed  CAS  Google Scholar 

  19. Serrao KL, Fortenberry JD, Owens ML, Harris FL, Brown LA (2001) Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand. Am J Physiol Lung Cell Mol Physiol 280:L298–L305

    PubMed  CAS  Google Scholar 

  20. Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ (1996) Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med 184:429–440. doi:10.1084/jem.184.2.429

    Article  PubMed  CAS  Google Scholar 

  21. Kiener PA, Davis PM, Rankin BM et al (1997) Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation. J Immunol 159:1594–1598

    PubMed  CAS  Google Scholar 

  22. Nagata S (1997) Apoptosis by death factor. Cell 88:355–365. doi:10.1016/S0092-8674(00)81874-7

    Article  PubMed  CAS  Google Scholar 

  23. Kischkel FC, Hellbardt S, Behrmann I et al (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14:5579–5588

    PubMed  CAS  Google Scholar 

  24. Medema JP, Scaffidi C, Kischkel FC et al (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16:2794–2804. doi:10.1093/emboj/16.10.2794

    Article  PubMed  CAS  Google Scholar 

  25. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407:770–776. doi:10.1038/35037710

    Article  PubMed  CAS  Google Scholar 

  26. Susin SA, Lorenzo HK, Zamzami N et al (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397:441–446. doi:10.1038/17135

    Article  PubMed  CAS  Google Scholar 

  27. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES et al (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479–489. doi:10.1016/S0092-8674(00)80434-1

    Article  PubMed  CAS  Google Scholar 

  28. Kagi D, Vignaux F, Ledermann B et al (1994) Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528–530. doi:10.1126/science.7518614

    Article  PubMed  CAS  Google Scholar 

  29. Lowin B, Hahne M, Mattmann C, Tschopp J (1994) Cytotoxic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650–652. doi:10.1038/370650a0

    Article  PubMed  CAS  Google Scholar 

  30. Rodriguez I, Matsuura K, Ody C, Nagata S, Vassalli P (1996) Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J Exp Med 184:2067–2072. doi:10.1084/jem.184.5.2067

    Article  PubMed  CAS  Google Scholar 

  31. Eguchi S, Matsuzaki S, Fujioka H, Koji T, Higami Y, Kanematsu T (1998) The Fas/Fas-ligand system function in hepatocytes in the early stage of fulminant hepatic failure in rats. Hepatol Res 11:103–114. doi:10.1016/S1386-6346(98)00020-5

    Article  Google Scholar 

  32. Tordjmann T, Soulie A, Guettier C et al (1998) Perforin and granzyme B lytic protein expression during chronic viral and autoimmune hepatitis. Liver 18:391–397

    PubMed  CAS  Google Scholar 

  33. Lin MT, Stohlman SA, Hinton DR (1997) Mouse hepatitis virus is cleared from the central nervous system of mice lacking perforin-mediated cytolysis. J Virol 71:383–391

    PubMed  CAS  Google Scholar 

  34. Watanabe Y, Morita M, Akaike T (1996) Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury. Hepatology 24:702–710. doi:10.1002/hep.510240338

    Article  PubMed  CAS  Google Scholar 

  35. Kitamura Y, Hashimoto S, Mizuta N et al (2001) Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice. Am J Respir Crit Care Med 163:762–769

    PubMed  CAS  Google Scholar 

  36. Albertine KH, Soulier MF, Wang Z et al (2002) Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am J Pathol 161:1783–1796

    PubMed  CAS  Google Scholar 

  37. Hashimoto S, Kobayashi A, Kooguchi K, Kitamura Y, Onodera H, Nakajima H (2000) Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am J Respir Crit Care Med 161:237–243

    PubMed  CAS  Google Scholar 

  38. Mizuta M, Nakajima H, Mizuta N et al (2008) Fas ligand released by activated monocytes causes apoptosis of lung epithelial cells in human acute lung injury model in vitro. Biol Pharm Bull 31:386–390. doi:10.1248/bpb.31.386

    Article  PubMed  CAS  Google Scholar 

  39. Hakuno N, Koji T, Yano T et al (1996) PKFas/APO-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia. Endocrinology 137:1938–1948. doi:10.1210/en.137.5.1938

    Article  PubMed  CAS  Google Scholar 

  40. Koji T, Hishikawa Y, Ando H, Nakanishi Y, Kobayashi N (2001) Expression of Fas and Fas ligand in normal and ischemia-reperfusion testes: involvement of the Fas system in the induction of germ cell apoptosis in the damaged mouse testis. Biol Reprod 64:946–954. doi:10.1095/biolreprod64.3.946

    Article  PubMed  CAS  Google Scholar 

  41. Kayagaki N, Yamaguchi N, Nagao F et al (1997) Polymorphism of murine Fas ligand that affects the biological activity. Proc Natl Acad Sci USA 94:3914–3919. doi:10.1073/pnas.94.8.3914

    Article  PubMed  CAS  Google Scholar 

  42. Ejima K, Koji T, Tsuruta D, Nanri H, Kashimura M, Ikeda M (2000) Induction of apoptosis in placentas of pregnant mice exposed to lipopolysaccharides: possible involvement of Fas/Fas ligand system. Biol Reprod 62:178–185. doi:10.1095/biolreprod62.1.178

    Article  PubMed  CAS  Google Scholar 

  43. Seko Y, Kayagaki N, Seino K, Yagita H, Okumura K, Nagai R (2002) Role of Fas/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by Coxsackievirus B3. J Am Coll Cardiol 39:1399–1403. doi:10.1016/S0735-1097(02)01776-X

    Article  PubMed  CAS  Google Scholar 

  44. Seino K, Iwabuchi K, Kayagaki N et al (1998) Chemotactic activity of soluble Fas ligand against phagocytes. J Immunol 161:4484–4488

    PubMed  CAS  Google Scholar 

  45. Shibuya H, Ohkohchi N, Tsukamoto S, Satomi S (1997) Tumor necrosis factor-induced, superoxide-mediated neutrophils accumulation in cold ischemia/reperfused rat liver. Hepatology 26:113–120. doi:10.1002/hep.510260115

    Article  PubMed  CAS  Google Scholar 

  46. Rudiger HA, Clavien PA (2002) Tumor necrosis factor a, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology 122:202–210. doi:10.1053/gast.2002.30304

    Article  PubMed  CAS  Google Scholar 

  47. Stephen WC, Pauline DT, Daniel GR, Wendy ES, Steven LK (1991) In vivo biologic and immunohistochemical analysis of interleukin-1 α, β and tumor necrosis factor during experimental endotoxemia. Am J Pathol 138:395–402

    Google Scholar 

  48. Li SQ, Liang LJ, Huang JF, Li Z (2003) Hepatocyte apoptosis induced by hepatic ischemia-reperfusion injury in cirrhotic rats. Hepatobiliary Pancreat Dis Int 2:102–105

    PubMed  CAS  Google Scholar 

  49. Li X, Zhang JF, Lu MQ, Yang Y, Xu C, Li H et al (2007) Alleviation of ischemia-reperfusion injury in rat liver transplantation by induction of small interference RNA targeting Fas. Langenbecks Arch Surg 392:345–351. doi:10.1007/s00423-006-0142-5

    Article  PubMed  CAS  Google Scholar 

  50. Mukhopadhyay A, Ni J, Zhai Y, Yu GL (1999) Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-κB, and c-Jun NH2-terminal kinase. J Biol Chem 274:15978–15981. doi:10.1074/jbc.274.23.15978

    Article  PubMed  CAS  Google Scholar 

  51. Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A, Green DR (1998) DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol Cell 1:543–551. doi:10.1016/S1097-2765(00)80054-4

    Article  PubMed  CAS  Google Scholar 

  52. Brown S, Savill J (1999) Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes. J Immunol 162:480–485

    PubMed  CAS  Google Scholar 

  53. Park DR, Thomsen AR, Frevert CW et al (2003) Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J Immunol 170:6209–6216

    PubMed  CAS  Google Scholar 

  54. Tsutsui H, Matsui K, Okamura H, Nakanishi K (2000) Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol Rev 174:192–209. doi:10.1034/j.1600-0528.2002.017418.x

    Article  PubMed  CAS  Google Scholar 

  55. Morita M, Watanabe Y, Akaike T (1995) Protective effect of hepatocyte growth factor on interferon-γ induced cytotoxicity in mouse hepatocytes. Hepatology 21:1585–1593

    PubMed  CAS  Google Scholar 

  56. Leithauser F, Dhein J, Mechtersheimer G et al (1993) Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily in normal and neoplastic cells. Lab Invest 69:415–429

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Junji Magae.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakajima, H., Mizuta, N., Fujiwara, I. et al. Blockade of the Fas/Fas ligand interaction suppresses hepatocyte apoptosis in ischemia-reperfusion rat liver. Apoptosis 13, 1013–1021 (2008). https://doi.org/10.1007/s10495-008-0234-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10495-008-0234-5

Keywords

Navigation